Metastatic Prostate Cancer
Metastatic prostate cancer is a stage of prostate cancer where the disease has spread from the prostate gland to other parts of the body, often leading to more severe symptoms and requiring advanced treatment options.
Prostate Cancer: Re-treatment with [177Lu]Lu-PSMA
We are studying the effects of re-treating men with metastatic castration-resistant prostate cancer using [177Lu]Lu-PSMA. This trial aims to see if this treatment can help improve survival and quality of life.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you a male aged 18 years or older?
- Have you been treated with at least one androgen receptor signaling inhibitor (like Enzalutamide or Abiraterone) for prostate cancer?
- Have you received at least one type of chemotherapy (like Docetaxel or Cabazitaxel) for your prostate cancer?
- Do you have prostate cancer that has spread to other parts of your body, confirmed by imaging tests?
- Have you had any serious heart problems or other major health issues that could affect your participation?
What similar medicines might you know?
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Illuccix
Isoprotrace
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
University Hospital Of Clermont-Ferrand
Oncologie médicale
Beaumont, France
Institut Bergonie
Medecine Nucléaire
Bordeaux, France
Centre Hospitalier Regional Et Universitaire De Brest
Oncologie médicale
Brest, France
Sponsor: Hospices Civils De Lyon
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.